Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroepidemiology of Maternally-derived Antibody Against Group B Streptococcus (GBS) in Mulago/Kawempe Hospitals Uganda

NCT04549220 is registered in ClinicalTrials.gov with St George's, University of London as lead sponsor.

NCT NCT04549220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04549220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroepidemiology of Maternally-derived Antibody Against Group B Streptococcus (GBS) in Mulago/Kawempe Hospitals Uganda
Lead sponsor
St George's, University of London
Phase
Observational
Overall status
Active, not recruiting
Start date
April 24, 2019
Completion date
July 30, 2025
Enrollment
6,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

group b strep infection, group b streptococcal infection, early-onset, group b streptococcal infection, late-onset, group b streptococcus carrier in childbirth, group b streptococcus neonatal sepsis